Effect of a new vitamin E-coated membrane on glycoxidation during hemodialysis

Contributions to Nephrology

Volumn 127, Issue , 1999, Pages 192-199

  Odetti, P ^a   Robaudo, C ^a   Valentini, S ^a   Gurreri, G ^a   Garibaldi, S ^a   Angeletti, S ^a   Deferrari, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; DRUG DERIVATIVE; LYSINE; PENTOSIDINE;

AGED; ARTICLE; ARTIFICIAL MEMBRANE; BLOOD; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

AGED; ANTIOXIDANTS; ARGININE; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIPID PEROXIDATION; LYSINE; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; RENAL DIALYSIS; VITAMIN E;

EID: 0033250936     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (26)

1. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER: Oxidative stress in haemodialysis. Q J Med 1994;87:679-683.
2. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-1313.
3. Schettler V, Wieland E, Verwiebe R, Schuff-Werner P, Scheler F, Oellerch M: Plasma lipids are not oxidized during hemodialysis. Nephron 1994;67:42-47.
4. Toborek M, Wasik T, Drozdz M, Klin M, Magner-Wrobel K, Kopieczna-Grzebieniak E: Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 1992;41:1229-1232.
5. 2-microglobulin treated with oxygen-derived radicals. Biochem J 1991;277:175-182.
6. Hassan MQ, Hussain SA, Zaki MA, Alsharif NZ, Stohs SJ: Protective effects of antioxidants against uraemia-induced lipid peroxidation and glutathione depletion in humans. Pharmacol Toxicol 1995;77:407-411.
7. Cristol JP, Bosc JY, Badiou S, Leblanc M, Lorrho R, Descamps B, Canaud B: Erythropoietin and oxidative stress in haemodialysis: Beneficial effects of vitamin E supplementation. Nephrol Dial Transplant 1997;12:2312-2317.
8. Ritz E, Deppisch R, Nawroth P: Toxicity off uraemia - does it come of AGE? Nephrol Dial Transplant 1994;9:1-2.
9. Odetti P, Cosso L, Pronzato MA, Dapino D, Gurreri G: Plasma advanced glycation end-products in maintenance haemodialysis patients. Nephrol Dial Transplant 1995;10:2110-2113.
10. Miyata T, Maeda K, Kurokawa K, van Ypersele de Strihou C: Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant 1997; 12:255-258.
11. Kristal BS, Yu BP: An emerging hypothesis: Synergistic induction of ageing by free radicals and Maillard reaction. J Gerontol 1992;47:B107-B114.
12. Odetti P, Fogarty J, Sell DR, Monnier VM: Chromatographic quantitation of plasma and red blood cell pentosidine in diabetic and uremic subjects. Diabetes 1992;41:153-159.
13. Young IS, Trimble ER: Measurement of malondialdehyde in plasma by high-performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991;28:504-508.
14. Nair V, Vietti DE, Cooper CS: Degenerative chemistry of malondialdehyde. Structure, stereochemistry, and kinetics of formation of enaminals from reaction with amino acids. J Am Chem Soc 1981;103:3030-3036.
15. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER: Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186:464-479.
16. Odetti P, Garibaldi S, Gurreri G, Aragno I, Dapino D, Pronzato MA, Marinari UM: Protein oxidation in hemodialysis and transplantation. Metabolism 1996;45:1319-1322.
17. Rock CL, Jahnke MG, Gorenflo DW, Swartz RD, Messana JM: Racial group differences in plasma concentrations of antioxidant vitamins and carotenoids in hemodialysis patients. Am J Clin Nutr 1997;65:844-850.
18. Daschner M, Lenhartz H, Botticher D, Schaefer F, Wollschlager M, Mehls O, Leichsenring M: Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int 1996; 50:1268-1272.
19. Sutherland WH, Walker RJ, Ball MJ, Stapley SA, Robertson MC: Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int 1995;48:227-236.
20. Loughrey CM, Young IS, McEneny J, McMaster C, McNamee PT, Trimble ER: Oxidation of low density lipoprotein in patients on regular haemodialysis. Atherosclerosis 1994;110:185-193.
21. Durak I, Akyol Ö, Basesme E, Canbolat O, Kavutçu M: Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron 1994;66:76-80.
22. 2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Soc Acad Sci USA 1996;93:2353-2358.
23. Ueda Y, Miyata T, Hashimoto T, Yamada H, Izuhara Y, Sakai H, Kurokawa K: Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia. Biochem Biophys Res Commun 1998;245:785-790.
24. Buoncristiani U, Galli F, Rovidati S, Albertini MC, Campus G, Canestrari F: Oxidative damage during hemodialysis using a vitamin-E-modified dialysis membrane: A preliminary characterization. Nephron 1997;77:57-61.
25. Odetti P, Gurreri G, Garibaldi S, Cosso L, Aragno I, Valentini S, Pronzato MA, Marinari UM: Oxidative damage to proteins and abnormal concentration of pentosidine during haemodialysis and after renal transplantation. Abstr 6th Int Symp of the Mailllard Reaction, 27-30 July, London 1997, p 176.
26. Odetti P, Garibaldi S, Cosso L, Valentini S, Pronzato MA, Robaudo C, Gurreri G: Effect of vitamin E supplementation on AGE in subjects on regular hemodialysis (in preparation).